A study of nipocalimab or intravenous immunoglobulin in pregnancies at risk of fetal and neonatal alloimmune thrombocytopaenia

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2024
This article has no abstract
Epistemonikos ID: 5ee8b879f1630ac3ea9dd868bbc5136ead8b27b3
First added on: Jan 17, 2025